Latest News & Features
Americas
Japan-based pharmaceutical company Daiichi Sankyo has secured victory in an inter partes review against Canada-based Alethia Biotherapeutics. 20 June 2016
Americas
Business law firm Procopio has added Robert Ramos as a partner in its life sciences practice group in San Diego. 20 June 2016
Americas
Authorities in Arizona arrested 26 people, while 23 businesses were raided, in a counterfeit prescription drug operation last Wednesday. 17 June 2016
Americas
The US Court of Appeals for the Federal Circuit decided on June 14 that the two patents involved in a dispute between Biomarin Pharmaceuticals and Genzyme Therapeutic Products are unpatentable due to being obvious. 16 June 2016
Video
In a video interview that was conducted at the 2016 BIO International Convention last week, LSIPR spoke to Crawford Jones, ISS media specialist from NASA, and Michael Roberts, deputy chief scientist from partner organisation CASIS, about using space as an environment for research as well as NASA’s relationship with intellectual property. 16 June 2016
Asia
In a recent decision in India, biopharma company Biocon and its partner Mylan were allowed to continue marketing a biosimilar breast cancer drug, as Vikrant Rana and Sanjeeta Das of SS Rana report. 16 June 2016
Africa
The “Global Generic Drugs Market 2016-2020” report predicts that the expiry of patents for branded drugs, worth $150 billion, will allow generic companies to prosper by 2020. 15 June 2016
Big Pharma
The German Federal Supreme Court has granted Eli Lilly an appeal in the patent infringement case against its rival Actavis regarding the Alimta drug. 15 June 2016
Big Pharma
Ahead of the Life Sciences Law Forum 2016, which takes place on June 23 at Etc Venues in the City of London, LSIPR previews some of the main discussion points. 15 June 2016
Big Pharma
The English High Court made its decision on the UK Hospira and Cubist Pharmaceuticals patent dispute last Friday, June 10, concluding that three Cubist-owned patents are invalid. 15 June 2016